Straits Times Index
3,213.65 -26.93 (-0.83%) S&P 500
3,901.36 +0.57 (+0.01%) Dow
31,261.90 +8.80 (+0.03%) Nasdaq
11,354.62 -33.88 (-0.30%) BTC-USD
30,393.37 +522.41 (+1.75%) CMC Crypto 200
682.15 +8.78 (+1.30%)
Cannabis stocks
159.97k followers • 18 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Curated by Yahoo Finance
Global spending on legal cannabis worldwide will hit over £43 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalisation of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the US is projected to hit £17.8 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.
How do we pick these stocks?This is a curated list, powered by Yahoo Finance’s algorithm and intelligence from our millions of users as well as the Yahoo Finance editorial team. The list covers companies in horticulture, pharmaceutical research and ancillary businesses. We will continue to add names as corporations invest and pivot into the space.
How are these weighted?The stocks on this watchlist are weighted equally at the time they were added.
To learn what every company on this list is doing that involves cannabis, read this story.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| Cannabis stocks | -0.63% | +58.10% | -9.72% | +327.19% |
| ^GSPC | +0.01% | -9.19% | -7.04% | +4095.01% |
18 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | 151.01 | -0.71 | -0.47% | 4:03 pm GMT-4 | 6.75M | 7.55M | 266.85B |
| BUD | Anheuser-Busch InBev SA/NV | 54.27 | +0.21 | +0.39% | 4:00 pm GMT-4 | 1.14M | 1.73M | 109.38B |
| MO | Altria Group, Inc. | 51.09 | - | - | 4:03 pm GMT-4 | 16.22M | 10.13M | 92.50B |
| TAP | Molson Coors Beverage Company | 51.23 | +0.45 | +0.89% | 4:04 pm GMT-4 | 1.62M | 1.66M | 11.13B |
| SMG | The Scotts Miracle-Gro Company | 91.01 | -0.35 | -0.38% | 4:00 pm GMT-4 | 309.25k | 538.64k | 5.04B |
| WEED.TO | Canopy Growth Corporation | 7.09 | -0.42 | -5.59% | 3:59 pm GMT-4 | 2.34M | 2.58M | 2.83B |
| TLRY | Tilray Brands, Inc. | 4.72 | -0.14 | -2.88% | 4:00 pm GMT-4 | 20.28M | 35.95M | 2.35B |
| CGC | Canopy Growth Corporation | 5.52 | -0.35 | -5.96% | 4:00 pm GMT-4 | 6.39M | 7.20M | 2.20B |
| CRON | Cronos Group Inc. | 3.39 | -0.03 | -0.88% | 4:00 pm GMT-4 | 1.21M | 2.29M | 1.27B |
| ACB | Aurora Cannabis Inc. | 2.93 | -0.11 | -3.62% | 4:00 pm GMT-4 | 7.03M | 7.40M | 664.52M |
| TGODF | The Green Organic Dutchman Holdings Ltd. | 0.0793 | +0.00 | +0.76% | 3:58 pm GMT-4 | 497.43k | 381.45k | 61.51M |
| NBEV | NewAge, Inc. | 0.3767 | +0.01 | +3.66% | 4:00 pm GMT-4 | 1.14M | 1.41M | 55.30M |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 0.341 | -0.01 | -1.93% | 4:00 pm GMT-4 | 1.25M | 1.61M | 42.71M |
| CANN | General Cannabis Corp | 0.2922 | -0.02 | -5.57% | 3:41 pm GMT-4 | 27.60k | 116.52k | 28.11M |
| MJ | ETFMG Alternative Harvest ETF | 7.6 | -0.18 | -2.31% | 4:00 pm GMT-4 | 1.26M | 1.39M | - |
- Reuters
Cold beer to your door: brewers in Latin America go direct
With COVID-19 lockdowns normalising home delivery of everything from fast food to aspirin, brewers are tapping into a lucrative new sales format - delivering cold beer on demand to consumers still gathering at home with friends even as bars reopen. For Brazilian Rafael Mazaia, it is cheaper to order beers for delivery to his home than to drive to the supermarket to pick up a pack and risk them being tepid when he returns. The world's largest brewer Anheuser-Busch InBev saw orders at its cold beer service Ze Delivery, launched in its second-largest market Brazil in 2016, explode during the pandemic from 1.5 million in 2019 to 62 million last year.
- PR Newswire
CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Ulcerative Colitis
AbbVie (NYSE: ABBV) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib (RINVOQ®, 45 mg [induction dose] and 15 mg and 30 mg [maintenance dose]) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.*
- InvestorPlace
7 Retirement Stocks to Buy for Any Market Conditions
Although the market turmoil may have investors scrambling for cover, these retirement stocks can likely withstand the heat. Brookfield Infrastructure (BIPC): One of the largest owners and operators of critical global infrastructure networks, Brookfield presents unbeatable relevance. Duke Energy (DUK): A classic name among retirement stocks, Duke Energy’s pertinent business and compelling coverage map make it a worthwhile idea. American Electric Power Company (AEP): A massive electric utility fir
